Portage Biotech
PRTG
#10226
Rank
NZ$26.72 M
Marketcap
Country
NZ$11.73
Share price
-2.16%
Change (1 day)
77.14%
Change (1 year)

Earnings for Portage Biotech (PRTG)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Portage Biotech's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.3 Billion a decrease over its 2022 earnings that were of -NZ$29.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Portage Biotech from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion-56.73%
2023 -NZ$0.3 Billion891.76%
2022 -NZ$29.39 Million-18.44%
2021 -NZ$36.03 Million348.58%
2020 -NZ$8.04 Million-39.96%
2019 -NZ$13.38 Million-106.26%
2018 NZ$0.21 B-621.51%
2017 -NZ$41 Million-213.76%
2016 NZ$36.03 M-336.72%
2015 -NZ$15.23 Million81.72%
2014 -NZ$8.38 Million-4.91%
2013 -NZ$8.81 Million
2007 -NZ$0.02 Million-101.23%
2006 NZ$1.58 M-116.89%
2005 -NZ$9.36 Million264.28%
2004 -NZ$2.57 Million650.8%
2003 -NZ$0.35 Million-54.15%
2002 -NZ$0.75 Million11.37%
2001 -NZ$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
NZ$47.48 M-135.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-NZ$3.73 Million-97.24% Bahamas